Genmab A/S S/Adr

(GMXAY)

By |

Profile

Genmab A/S is an antibody company focused on cancer. Its first marketed product is Arzerra (ofatumumab); development pipeline incl. daratumumab and two proprietary technology platforms; DuoBody (bispecifics) & HexaBody (effector function enhancement).

Contact Information

Website: www.genmab.com
Main Phone: +45 70202728
Address: Bredgade 34E
City / Town: Copenhagen K
Country: DNK
Postal Code: 1260

Issuer Information

Exchange: OTO
Employees: 189
$ 104.69 $ -0.972 (-0.92%)
Last Price 104.69 Change $ -0.972 Change % -0.92 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 104.85 High 104.85 Low 104.69 Prev Close 105.67
Last Trade Volume 478 52 Wk Hi 117.75 52 Wk Low 79.72
Market Cap 12.8 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 122,126,284.00 EPS (TTM) 1.57 PE Ratio 67.40 Exchange OTCPK